Theravance Biopharma Files 8-K Report
Ticker: TBPH · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1583107
| Field | Detail |
|---|---|
| Company | Theravance Biopharma, Inc. (TBPH) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Theravance Biopharma filed an 8-K on June 10, 2025, covering other events and financials.
AI Summary
On June 10, 2025, Theravance Biopharma, Inc. filed an 8-K report detailing other events and financial statements. The company, incorporated in the Cayman Islands with its principal executive offices at 901 Gateway Boulevard, South San Francisco, CA, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing provides an update on Theravance Biopharma's corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K report, which typically contains standard corporate disclosures and does not indicate immediate significant risk.
Key Numbers
- 001-36033 — Commission File Number (Identifies the company's filing with the SEC)
- 98-1226628 — I.R.S. Employer Identification Number (Tax identification number for the company)
Key Players & Entities
- Theravance Biopharma, Inc. (company) — Registrant
- June 10, 2025 (date) — Date of earliest event reported
- 901 Gateway Boulevard, South San Francisco, CA 94080 (address) — Principal executive offices
- Cayman Islands (jurisdiction) — State or Other Jurisdiction of Incorporation
- 001-36033 (identifier) — Commission File Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of June 10, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 10, 2025.
Where are Theravance Biopharma's principal executive offices located?
Theravance Biopharma's principal executive offices are located at 901 Gateway Boulevard, South San Francisco, CA 94080.
In which jurisdiction is Theravance Biopharma, Inc. incorporated?
Theravance Biopharma, Inc. is incorporated in the Cayman Islands.
What is the Commission File Number for Theravance Biopharma, Inc.?
The Commission File Number for Theravance Biopharma, Inc. is 001-36033.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Theravance Biopharma, Inc. (TBPH).